Back
Esquire Financial Holdings, Inc. Vs. Rapt Therapeutics, Inc. Industry Stock Comparison
Buy
60
ESQ
Esquire Financial Holdings, Inc.
Last Price:
$102.03
Seasonality Move:
0.09%
Sell
38
RAPT
Rapt Therapeutics, Inc.
Last Price:
$33.92
Seasonality Move:
-28.15%
Buy
60
Esquire Financial Holdings, Inc. (ESQ)
is a Buy
Is Esquire Financial Holdings, Inc. a Buy, Sell or Hold?
-
The current Esquire Financial Holdings, Inc. [ESQ] share price is $102.23. The Score for ESQ is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ESQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $33.38. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESQ Stock Price Chart
What is Esquire Financial Holdings, Inc.'s stock price today?
-
The Esquire Financial Holdings, Inc. share price today is $102.23Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ESQ is experiencing selling pressure, which indicates risk of future bearish movement.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $33.38The current trend is moderately bullish and RAPT is experiencing selling pressure, which indicates risk of future bearish movement.
ESQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.94 | Buy |
| Relative Strength Index (14 RSI): | 43.64 | Sell |
| Chaikin Money Flow: | -22425 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.65 - 106.79) | Sell |
| Bollinger Bands (100): | (96.72 - 104.28) | Buy |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.71 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | -220916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.11 - 35.93) | Sell |
| Bollinger Bands (100): | (16.49 - 33.77) | Buy |
ESQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.67 | Sell |
| 20-day SMA: | 105.37 | Sell |
| 50-day SMA: | 101.24 | Buy |
| 200-day SMA: | 94.34 | Buy |
| 8-day EMA: | 104.88 | Sell |
| 20-day EMA: | 104.6 | Sell |
| 50-day EMA: | 102.58 | Sell |
| 200-day EMA: | 94.28 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.03 | Sell |
| 20-day SMA: | 34.65 | Sell |
| 50-day SMA: | 31.71 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 31.26 | Buy |
| 20-day EMA: | 20.72 | Buy |
| 50-day EMA: | 10.54 | Buy |
| 200-day EMA: | 3 | Buy |
Esquire Financial Holdings, Inc. Earnings Growth & ESQ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.62 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.
Esquire Financial Holdings, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||